FDA OKs 2-Drug Combo Treatment for Advanced Melanoma

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

In trial, Mekinist and Tafinlar together seemed to perform better than Tafinlar alone, agency says

 

0 Comments

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.